182 related articles for article (PubMed ID: 10898417)
21. PLA1/A2 polymorphism of the platelet glycoprotein receptors IIIA in Behçet's disease.
Atzeni F; Boiardi L; Nicoli D; Farnetti E; Casali B; Sarzi-Puttini P; Pipitone N; Olivieri I; Cantini F; Salvi F; La Corte R; Triolo G; Filippini D; Paolazzi G; Salvarani C
Clin Exp Rheumatol; 2011; 29(4 Suppl 67):S38-43. PubMed ID: 21813062
[TBL] [Abstract][Full Text] [Related]
22. Effect of PlA1/A2 glycoprotein IIIa gene polymorphism on the long-term outcome after successful coronary stenting.
Le Hello C; Morello R; Lequerrec A; Duarte C; Riddell J; Hamon M
Thromb J; 2007 Nov; 5():19. PubMed ID: 18021403
[TBL] [Abstract][Full Text] [Related]
23. Platelet glycoprotein IIIa polymorphisms and risk of coronary stent thrombosis.
Walter DH; Schächinger V; Elsner M; Dimmeler S; Zeiher AM
Lancet; 1997 Oct; 350(9086):1217-9. PubMed ID: 9652563
[TBL] [Abstract][Full Text] [Related]
24. Acute myocardial infarction in young adults: prognostic role of angiotensin-converting enzyme, angiotensin II type I receptor, apolipoprotein E, endothelial constitutive nitric oxide synthase, and glycoprotein IIIa genetic polymorphisms at medium-term follow-up.
Brscic E; Bergerone S; Gagnor A; Colajanni E; Matullo G; Scaglione L; Cassader M; Gaschino G; Di Leo M; Brusca A; Pagano GF; Piazza A; Trevi GP
Am Heart J; 2000 Jun; 139(6):979-84. PubMed ID: 10827377
[TBL] [Abstract][Full Text] [Related]
25. Associations between a polymorphism in the gene encoding glycoprotein IIIa and myocardial infarction or coronary artery disease.
Anderson JL; King GJ; Bair TL; Elmer SP; Muhlestein JB; Habashi J; Carlquist JF
J Am Coll Cardiol; 1999 Mar; 33(3):727-33. PubMed ID: 10080474
[TBL] [Abstract][Full Text] [Related]
26. A1/A2 polymorphism of glycoprotein IIIa and association with excess procedural risk for coronary catheter interventions: a case-controlled study.
Laule M; Cascorbi I; Stangl V; Bielecke C; Wernecke KD; Mrozikiewicz PM; Felix SB; Roots I; Baumann G; Stangl K
Lancet; 1999 Feb; 353(9154):708-12. PubMed ID: 10073513
[TBL] [Abstract][Full Text] [Related]
27. Platelet glycoprotein receptor IIIa polymorphism PLA1/PLA2 and coronary risk: a meta-analysis.
Di Castelnuovo A; de Gaetano G; Donati MB; Iacoviello L
Thromb Haemost; 2001 Apr; 85(4):626-33. PubMed ID: 11341496
[TBL] [Abstract][Full Text] [Related]
28. The prothrombin gene G20210A mutation and the platelet glycoprotein IIIa polymorphism PlA2 in patients with central retinal vein occlusion.
Larsson J; Hillarp A
Thromb Res; 1999 Nov; 96(4):323-7. PubMed ID: 10593436
[TBL] [Abstract][Full Text] [Related]
29. Development of a monoclonal antibody capable of differentiating platelet PLA1/PLA1, PLA1/PLA2 and PLA2/PLA2 genotypes.
Liu LX; Nardi M; Flug F; Karpatkin S
Br J Haematol; 1992 May; 81(1):113-7. PubMed ID: 1520609
[TBL] [Abstract][Full Text] [Related]
30. The PlA polymorphism of glycoprotein IIIa functions as a modifier for the effect of estrogen on platelet aggregation.
Boudoulas KD; Cooke GE; Roos CM; Bray PF; Goldschmidt-Clermont PJ
Arch Pathol Lab Med; 2001 Jan; 125(1):112-5. PubMed ID: 11151063
[TBL] [Abstract][Full Text] [Related]
31. Polymorphism of platelet glycoprotein IIb and risk of thrombosis and restenosis after coronary stent placement.
Böttiger C; Kastrati A; Koch W; Mehilli J; von Beckerath N; Dirschinger J; Gawaz M; Schömig A
Am J Cardiol; 1999 Nov; 84(9):987-91. PubMed ID: 10569651
[TBL] [Abstract][Full Text] [Related]
32. Prospective analysis after coronary-artery bypass grafting: platelet GP IIIa polymorphism (HPA-1b/PIA2) is a risk factor for bypass occlusion, myocardial infarction, and death.
Zotz RB; Klein M; Dauben HP; Moser C; Gams E; Scharf RE
Thromb Haemost; 2000 Mar; 83(3):404-7. PubMed ID: 10744144
[TBL] [Abstract][Full Text] [Related]
33. Glycoprotein IIIa polymorphism and risk of myocardial infarction.
Samani NJ; Lodwick D
Cardiovasc Res; 1997 Mar; 33(3):693-7. PubMed ID: 9093541
[TBL] [Abstract][Full Text] [Related]
34. [Is PLA1/A2 gene polymorphism of platelet membrane glycoprotein IIIa a risk factor for myocardial infarct?].
Melus V; Pullmann R; Hybenova J; Skerenova M; Pullmann R
Bratisl Lek Listy; 1999 Nov; 100(11):593-7. PubMed ID: 10758736
[TBL] [Abstract][Full Text] [Related]
35. The GPIIIa PlA polymorphism and the platelet hyperactivity in Tunisian patients with stable coronary artery disease treated with aspirin.
Abderrazek F; Chakroun T; Addad F; Dridi Z; Gerotziafas G; Gamra H; Hassine M; Elalamy I
Thromb Res; 2010 Jun; 125(6):e265-8. PubMed ID: 20138334
[TBL] [Abstract][Full Text] [Related]
36. Relationship between bleeding time, aspirin and the PlA1/A2 polymorphism of platelet glycoprotein IIIa.
Szczeklik A; Undas A; Sanak M; Frolow M; Wegrzyn W
Br J Haematol; 2000 Sep; 110(4):965-7. PubMed ID: 11054089
[TBL] [Abstract][Full Text] [Related]
37. The PlA1/A2 polymorphism of platelet glycoprotein IIIa is not associated with the risk of type 2 diabetes. The Ludwigshafen Risk and Cardiovascular Health study.
März W; Boehm BO; Winkelmann BR; Hoffmann MM;
Diabetologia; 2004 Nov; 47(11):1969-73. PubMed ID: 15565371
[TBL] [Abstract][Full Text] [Related]
38. A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis.
Weiss EJ; Bray PF; Tayback M; Schulman SP; Kickler TS; Becker LC; Weiss JL; Gerstenblith G; Goldschmidt-Clermont PJ
N Engl J Med; 1996 Apr; 334(17):1090-4. PubMed ID: 8598867
[TBL] [Abstract][Full Text] [Related]
39. [Integrin Beta 3 PlA1/PlA2 polimorphism does not contribute to complications in both type 1 and type 2 diabetes].
Pucci L; Lucchesi D; Fotino C; Grupillo M; Miccoli R; Penno G; Del Prato S
G Ital Nefrol; 2003; 20(5):461-9. PubMed ID: 14634961
[TBL] [Abstract][Full Text] [Related]
40. Glycoprotein IIIA gene (PlA) polymorphism and aspirin resistance: is there any correlation?
Papp E; Havasi V; Bene J; Komlosi K; Czopf L; Magyar E; Feher C; Feher G; Horvath B; Marton Z; Alexy T; Habon T; Szabo L; Toth K; Melegh B
Ann Pharmacother; 2005 Jun; 39(6):1013-8. PubMed ID: 15840736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
